Synaptic transmission
between embryonic chick dorsal root ganglion (DRG) neurons and spinal cord neurons was studied in dissociated cell culture. Stimulation of DRG neurons evoked monosynaptic and polysynaptic excitatory responses in the spinal neurons. These responses could be reversibly blocked by application of 6-cyano-7-nitroquinoxaline-2,3-dione (a selective non-NMDA receptor antagonist) and irreversibly eliminated through the presynaptic action of w-conotoxin GVIA (a selective N-type calcium channel antagonist).
As N-type calcium channels in DRG neuron somata are targets for modulation via GABA, receptors, we tested the role of these receptors as regulators of synaptic transmission.
Baclofen (a selective GABA, receptor agonist) reversibly inhibited synaptic transmission via a presynaptic, pertussis toxin-sensitive mechanism; CGP 35348 (a selective GABA, receptor antagonist) blocked the actions of baclofen. Taken together, these results demonstrate that N-type calcium channels play a dominant role in glutamatergic sensory neurotransmission.
They suggest, in addition, that modulation of N-channel activity may underlie, at least in part, presynaptic inhibition of synaptic transmission between DRG neurons and their targets in the intact spinal cord.
[Key words: calcium channel, dorsal root ganglion, GABA, presynaptic inhibition, primaty afferent, synaptic transmission, 0-conotoxin] Sensory information from the skin, muscles, joints, and viscera is relayed to the CNS by dorsal root ganglion (DRG) neurons, which synapse in the spinal cord. DRG axons contain and release a number of putative neurotransmitters, including peptides such as substance P (Hokfelt et al., 1976; DeBiasi and Rustioni, 1988) and excitatory amino acids (EAAs) (Roberts, 1974; DeBiasi and Rustioni, 1988; Kangrga and Randic, 199 1) . Physiological data demonstrate that DRG neurons employ glutamate for fast, excitatory neurotransmission (Jahr and Jessell, 1985; Jesse11 et al., 1986) ; postsynaptic spinal neuron responses are mediated via both NMDA and non-NMDA type glutamatergic receptors (Yoshimura and Jessell, 1990; Pinto and Lev-Tov, 1991) . In addition, substance P released by DRG axon terminals elicits a low-amplitude, prolonged EPSP in spinal cord neurons (Urban and Randic, 1984; DeKoninck and Henry, 199 1; Yoshimura et al., 1992) .
Neurotransmission at the DRG-spinal cord synapse is subject to presynaptic regulation by spinal cord interneurons that synapse on DRG axon terminals (Barber et al., 1978) . GABAmediated presynaptic inhibition, in particular, appears to play a powerful regulatory role in both sensory and motor function. GABA and GABA receptor agonists have antinociceptive and antispastic effects and depress spinal reflexes (Paredes and Agmo, 1992) ; these actions have been shown to be mediated, at least in part, via GABA receptors on DRG axon terminals.
At least two classes of GABA receptor can be distinguished on the basis of their pharmacological properties: GABA, receptors, which are specifically activated by muscimol and blocked by convulsant agents such as bicuculline, and GABA, receptors, which are specifically activated by the antispastic drug baclofen and are blocked by CGP 35348 (Olpe et al., 1990) . Both GABA, and GABA, receptors appear to mediate presynaptic inhibition at the DRG-spinal neuron synapse. The pioneering studies on presynaptic inhibition by Eccles and colleagues described an activity-dependent depolarization at DRG nerve terminals, termed primary afferent depolarization (PAD), that was mediated by GABA (Eccles et al., 196 1, 1963) . PAD is hypothesized to inhibit transmitter release by reducing the potential change that occurs during a presynaptic action potential and, consequently, reducing calcium influx into the terminal (Eccles, 1964) . PAD is blocked by bicuculline and picrotoxin and is thus likely to be mediated by GABA, receptors (Eccles et al., 1963; Curtis et al., 1971; Barker and Nicoll, 1973) .
Evidence has accumulated over the past decade that presynaptic inhibition of DRG nerve terminals is also mediated by GABA, receptors. GABA, receptors are localized on primary afferent terminals (Price et al., 1984) and baclofen reduces transmitter release by primary afferents (Davies, 198 1) . Baclofen has been shown to reduce sensory neurotransmission, at least in part via a presynaptic mechanism, in numerous studies in vitro (Davies, 1981; Peng and Frank, 1989; Wang and Dun, 1990; Alford and Grillner, 1991; Kangrga et al., 1991) and in vivo (Dickenson et al., 1985; Lev-Tov et al., 1988; Jimenez et al., 199 1) . These actions are mechanistically distinct from GABA, receptor-mediated presynaptic responses; baclofen's presynaptic inhibitory actions occur in the absence of PAD and, not surprisingly, are unaffected by GABA, receptor blockers such as bicuculline.
The mechanisms that do underlie GABA, receptor-mediated presynaptic inhibition, however, are still controversial. Dunlap (198 1) and Dunlap and Fischbach (1981) demonstrated that GABA and baclofen inhibit voltage-gated calcium currents in DRG cell bodies. This finding led to the hypothesis (Dunlap, 198 1) that GABA causes presynaptic inhibition at DRG axon terminals via a GABA, receptor-mediated reduction of calcium current.
To characterize further the GABA, receptor-mediated inhibition of primary afferent terminals, we have established a coculture preparation consisting of dissociated embryonic chick DRG and spinal cord neurons. This has enabled us to make patch-clamp recordings from pairs of synaptically connected DRG and spinal cord neurons.
Portions of these data have been presented in abstract form (Gruner et al., 1992) .
Materials and Methods
Cell culture. The frequency of identifying synaptically coupled pairs of DRG and spinal cord cells varied depending upon culture methods employed. Our most successful experiments (76 synaptically coupled pairs in 220 pairs tested) were carried out on cells grown in the following way: spinal cords and dorsal root ganglia were dissected from 7 d chick embryos and separately incubated for 10 min at room temperature in 0.025% trypsin in Ca2+/MgZ+-free saline. The tissues were then separately resuspended in culture medium consisting of Eagle's Minimum Essential Medium (GIBCO) supplemented with 10% horse serum (GIB-CO). 5% chick embrvo extract. 50 U/ml nenicillin. 50 &ml strentomy&, and nerve growth factor (NGF). A crude prepara'iion of NGF was prepared by homogenizing male mouse salivary glands in distilled water and spinning out the particulate fraction at 20,000 x g for 60 min; 200 ~1 of supematant, containing the NGF, was added to 100 ml of the culture medium.
All tissue was triturated in this growth medium until mostly dissociated. The DRG cells were irradiated (5000 rads, cesium source) to prevent proliferation of non-neuronal ganglion cells. The spinal cord and DRG cells were then recombined and plated onto prepared culture dishes and grown at 37°C in 5% CO, for 5-14 d before recording.
Culture dishes were prepared using a modification of the technique of Segal and Furshpan (1990) . Thirty-five millimeter culture dishes were first coated with 0.15% agarose. After the agarose dried, an annulus of collagen was painted around the perimeter of each dish, and small collagen dots (0.2-0.3 mm diameter) were painted on the interior portion using a pulled tuberculin syringe. This procedure was motivated by the experimental constraint that only cell pairs within the microscopic field of view (-0.5 mm) could be simultaneously recorded. Because these neurons do not stick to agarose, their attachment and process outgrowth were confined to the collagen islands (Fig. 1) . By constraining the DRG axons to a single collagen island, we hoped to increase the number of synapses made onto nearby spinal cord neurons and thereby increase the proportion of recordable synaptically coupled pairs. The annulus of collagen provided a mass culture around the perimeter of the dish, which proved necessary for maintaining healthy neurons on the islands.
Solutions. All recordings were made at room temperature (22-26°C). Cells were visualized at a magnification of 5 12 x , using phase contrast optics on a Zeiss Axiovert microscope. The bath solution contained, in mM, NaCI, 145; KCl, 5; Na-HEPES, 10; M&I,, 1; CaCl,, 3: andglucose, 10. The electrode solution consisted of, in n&, .K-Asp, iO0; <Cl, 15: Na,ATP. 1.5: MgCI,. 1.5: EGTA. 10 -fih4 contami&ing Ca*+ 0.5: and Na-HEPES. 10. Assumine and using the equations of Fabiato and Fabiato (1979) , this solution would have a free calcium concentration of 2 nM. Extracellular solutions were exchanged via gravity flow and Inhibition of Sensory Neurotransmission vacuum suction at a flow rate of l-2 ml/min. The bath volume was kept approximately at 1 ml. Pertussis toxin (PTX) was stored as a stock solution of 170 &ml and diluted into culture medium at a final concentration of 170 @ml.
Electrical recording. Dual recordings of synaptically coupled neurons
were made in the current-clamp mode using two EPC7 patch-clamp amplifiers (List Electronics). Stimuli were applied by two S-100 stimulators (Medical Systems Corp.). Experiments were performed on line with the aid of a Data Translation 282 1 A/D converter and SPIKE (software written by Hilal Associates). Data were filtered at 2 kHz and acquired at 6 kHz. A List L/M-3P-A vertical two-stage puller was used to fabricate electrodes from thin-walled, borosilicate glass (World Precision Instruments, TWl50F-4) with resistances of 5-10 MU for the DRG cells and 10-l 5 MR for the spinal cord neurons. Because the EPC7 amplifiers have no bridge balance circuitry, the records shown include a slight error due to the electrode resistances. For the spinal neurons, which had input resistances in the OS-8 GQ range, this error was usually too small to see. For the lower-resistance DRG neurons, an instantaneous change in recorded potential accompanying the current stimulus is often visible and reflects the voltage drop across the recording electrode.
Results
Characteristics of the neurons in coculture As described first by Dichter and Fischbach (1977) , DRG neurons can be distinguished from spinal cord neurons both morphologically and electrophysiologically. In our experiments, DRG and spinal cord neurons were initially identified by their different morphologies. DRG neurons had large (-20-40 pm diameter), ellipsoid, phase-bright cell bodies with one or two processes; spinal cord neurons, by contrast, were small (-5-15 pm diameter) irregularly shaped, phase-dark cells with several highly branched processes (Fig. I ).
The two cell types were further distinguished in our experiments by their electrophysiological properties. DRG neurons were devoid of spontaneous synaptic potentials and typically had resting potentials between -50 and -60 mV. Somatic action potentials in DRG neurons rarely occurred spontaneously but could be routinely evoked by injecting depolarizing current. The action potentials generally exhibited a broad calcium-dependent plateau on the falling phase (varying from 3 to 20 msec in different cells). A small percentage of neurons morphologically identified as DRG neurons had no detectable calciumdependent plateau. We eliminated these from consideration in our studies of synaptic pairs in order to (1) avoid the possibility of mistakenly studying synapses between pairs of spinal neurons and (2) use the DRG somatic action potential duration as a monitor of the efficacy of applied transmitters. DRG action potentials exhibited a prominent but highly variable depolarizing afterpotential (Crain, 197 1; Dichter and Fischbach, 1977; see Fig. 4 ). This depolarization is thought to be mediated, at least in part, by a calcium-dependent chloride current (Mayer, 1985) .
In contrast, most spinal cord neurons (-80%) received frequent, spontaneous synaptic input that caused their membrane potentials to fluctuate greatly. As the input resistances of the spinal neurons were large (ranging from 0.5 to 8 Gn), the synaptic potentials were long lasting (see below) and often large enough to evoke spiking (e.g., Fig. 4B ). Spinal neuron action potential duration was uniformly brief (-2 msec on average) and lacked the calcium-dependent plateau and depolarizing afterpotential that characterize DRG neuron spikes.
Spatial control of voltage proved problematic in spinal cord neurons. For this reason, studies were performed using current clamp techniques only. Because of the spinal neurons' high input resistances, we have assumed that synaptic potentials (even from synapses removed from the cell body) are faithfully recorded; the rising phase of the synaptic potentials, under such conditions, provides a sensitive indicator of even small changes in postsynaptic conductance. In order to monitor excitatory synaptic potentials resulting from DRG neuron stimulation, spinal neurons were held at a membrane potential near -60 mV using hyperpolarizing current injection.
Synaptic coupling between DRG and spinal cord neurons Stimulation of action potentials in DRG neurons evoked fast excitatory synaptic potentials in the spinal cord neurons (Fig.   2 ). The proportion of recorded DRG-spinal cell pairs that were synaptically coupled varied greatly from plating to plating and ranged from 0 to 60% of pairs tested in any one experiment. Of a total of 400 pairs examined in our experiments, 105 were synaptically coupled. The latency between presynaptic stimulation and postsynaptic response was constant for a given synaptic pair and varied between 0.5 and 17.8 msec (n = 14). EPSPs were relatively long lasting, due to the large time constant of the spinal cord cell membranes. In 12 cells studied in which the monosynaptic response was unobscured by polysynaptic input, times to half-decay ranged from 19 to 120 msec and were positively correlated with input resistance. Transmitter release was calcium dependent; superfusion of the preparation with saline solutions containing 1 mM cobalt to block voltage-dependent calcium currents eliminated synaptic coupling (K. Dunlap, personal communication) . A small percentage of recorded pairs showed EPSPs that frequently failed or that ran down substantially during the course of the experiment. This was particularly common at the earliest culture ages studied (5-6 d in vitro). In order to minimize confounding effects of synaptic failure or fatigue, recordings were accepted for analysis only if an EPSP of near-constant amplitude could be reliably and repeatedly evoked. In addition, DRG neurons were routinely stimulated at low frequency (0.1 Hz) to avoid rundown. Data on inhibitory transmitter effects were accepted for analysis only when drug washout and reversal were achieved. Synaptic transmission between DRG and spinal neurons is glutamatergic Receptor antagonists were bath applied to determine whether synaptic transmission between DRG and spinal cord neurons in these cultures was mediated by glutamate, as is likely in vivo (Jesse11 et al., 1986; Yoshimura and Jessell, 1990) . Kynurenate, a relatively nonselective EAA receptor blocker (Perkins and Stone, 1982) , rapidly and reversibly eliminated the EPSPs at concentrations of 0.4-0.9 mM (n = 4; data not shown). To examine which glutamate receptor subtypes are involved in the postsynaptic response, we used specific antagonists to block the NMDA and non-NMDA types of glutamate receptor (Mayer and Westbrook, 1987; Honore et al., 1988) . The specific non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 2.5 PM) rapidly and reversibly blocked evoked postsynaptic responses in five of five pairs tested, without changing resting conductances or action potentials in the presynaptic DRG or postsynaptic spinal cord neurons (Fig. 2) . Spontaneous synaptic activity was also eliminated by CNQX. In contrast, the NMDA receptor antagonist 5-aminophosphonovalerate (APV, 100 FM) did not alter synaptic transmission in four of four pairs tested (data not shown). No action of APV on spontaneous synaptic activity was observed. (Nowycky et al., 1985; Kasai et al., 1987) . In this preparation these currents can be readily distinguished (Aosaki and Kasai, 1989; Cox and Dunlap, 1992) by w-conotoxin GVIA (w-CTX) block (N-type) and dihydropyridine sensitivity (L-type).
In the cocultures, bath application of 1 PM w-CTX produced an irreversibleblockade of evoked synaptic transmission in five of five pairs tested. This was accompanied by an elimination of the calcium-dependent action potential plateau in the DRG neuron (Fig. 3) . w-CTX did not alter the input resistance or membrane potential of the postsynaptic spinal cord neurons.
N-type calcium channels present in the somatic membranes of DRG neurons are targets for inhibitory modulation by transmitters such as GABA and norepinephrine (Miller, 1990) . This transmitter-induced modulation is reversible, has been pharmacologically characterized (Canfield and Dunlap, 1984) , and requires the activation of PTX-sensitive GTP-binding proteins (Holz et al., 1986) . In order to test whether N-channels in DRG nerve terminals (and, as a result, synaptic transmission) might be similarly modulated, we further characterized transmitter effects on synaptic activity.
To test whether w-CTX interfered with postsynaptic glutamate receptors, we compared the effects of puffer applications of L-glutamate on spinal neurons in the presence and absence of 1 PM w-CTX. Focal applications of L-glutamate (100 FM to 1 mM) depolarized the neurons. Glutamate-induced depolarizations were blocked by CNQX (10 PM in the bath and puffer pipette; n = 2). By contrast, inclusion of w-CTX (1 PM) in both the bath and puffer did not alter glutamate-induced depolarizations (n = 5; Fig. 5A,B) .
Transmission between DRG and spinal neurons was effectively suppressed by bath application of 1 O-l 00 PM baclofen, a specific GABA, receptor agonist, in most of the pairs tested (13 of 14 with 10 PM and 6 of 6 with 100 KM). Evoked EPSPs were abolished by 100 PM baclofen; 10 MM baclofen reduced EPSP amplitude by 50-l 00%. In all cases, the effects of baclofen were readily reversed by washing the bath for l-3 min with control saline solution. Baclofen-mediated inhibition (Fig. 4A ) occurred in the absence of any changes in spinal neuron input resistance or membrane potential. The time course of baclofen's effect on synaptic potential size was precisely correlated with the time course of baclofen's effect on the DRG somatic calcium-depen- Two traces from the spinal neuron recording are superimposed to illustrate the variability among responses. Near the end of the traces small (6 pA, 200 msec) hyperpolarizing current pulses were applied to the spinal neuron to monitor its input resistance. In 10 PM baclofen (center), the EPSPs were greatly reduced, with no apparent change in spinal neuron input resistance. The effects of baclofen were readily reversed on washing for 2 min (right): B, Cocultures were incubated in 170 &ml PTX for 24 hr at 37°C and then tested for sensitivity to baclofen. Multiple firing was rare for DRG cells but was not the result of PTX treatment; single spinal neuron responses are shown for clarity. Responses during (center) and after washout (right) 
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Control dent action potential plateau (Fig. 6) . However, the magnitudes of these effects differed; the DRG somatic action potential was typically only partially reduced by baclofen, while the synaptic potential was largely or completely abolished. In order to describe further the GABA, receptor that mediates baclofen's effects on synaptic transmission, we applied the potent and specific antagonist CGP 35348 (Olpe et al., 1990) . The inhibitory action of 10 PM baclofen on synaptic transmission was blocked in five of five pairs tested in the presence of 440 PM CGP 35348 (Fig. 7) . The action of the antagonist was reversible upon washing; that is, a second application of baclofen (following washout of CGP 35348) again produced suppression of synaptic transmission (data not shown).
To test whether baclofen interfered with postsynaptic glutamate receptors, we compared the effects of puffer applications of L-glutamate (100 I.LM to 1 mM) on spinal neurons in the presence and absence of baclofen. Baclofen (100 WM, in the bath and puffer pipette) did not alter glutamate-induced depolarizations (n = 5; Fig. 5C,D) .
In order to compare further the nerve terminal receptors that regulate release with those that regulate somatic calcium channels, we studied synaptic transmission in PTX-treated cells. Cocultures were incubated for 17-24 hr in 170 r&ml PTX at 37°C. Electrophysiological properties and synaptic responses in PTX-treated cells were indistinguishable from those in untreated controls. In contrast to untreated controls, however, synaptic transmission in PTX-treated cells was not modulated by 10 PM baclofen in any of the four pairs studied (Fig. 4B) .
In addition to GABA, other transmitters such as norepinephrine also modulate DRG somatic calcium currents (Rane and Dunlap, 1990) . In order to determine whether norepinephrine also modulates synaptic transmission, we tested its action on five DRG-spinal pairs. In one pair, norepinephrine (50 PM) reversibly eliminated synaptic transmission and produced a clear reduction in the somatic DRG action potential duration. For the remaining four pairs, however, there was no modulation of either synaptic transmission or the DRG somatic action potential.
Discussion
In order to study neurotransmission at the primary afferent synapse, we have made tight seal, whole-cell recordings from synaptically connected DRG-spinal neuron pairs grown in dissociated cell culture. Our data demonstrate that (1) synaptic transmission between embryonic DRG neurons and spinal neurons in vitro is primarily mediated by non-NMDA glutamate receptors; (2) o-CTX-sensitive, N-type calcium channels are necessary to trigger glutamate release from DRG axon terminals; and (3) baclofen inhibits synaptic transmission presynaptically by activating GABA, receptors coupled to PTX-sensitive GTP- Sensory neurotransmission in the spinal cord Biochemical and immunocytochemical studies indicate that DRG neurons contain and release a variety of putative transmitters, including EAAs and peptides. Postsynaptic spinal cord cells are responsive to many of these agents (Brown, 1982) . Despite this heterogeneity, L-glutamate is the most likely candidate for mediating fast synaptic transmission at the DRGspinal neuron synapse (Jahr and Jessell, 1985; Jesse11 et al., 1986) . Pharmacological studies in spinal cord slices have indicated that fast excitatory transmission is mediated primarily via non-NMDA type receptors, as indicated by sensitivity to CNQX and resistance to APV (Yoshimura and Jessell, 1990 ). The present findings in dissociated cell culture provide additional evidence that non-NMDA type glutamatergic receptors mediate fast, excitatory transmission between DRG and spinal cord neurons.
Sensory neurotransmission in the intact spinal cord is undoubtedly more complex than that seen in our culture system. By contrast to some previous reports using more intact spinal cord preparations (Dale and Grillner, 1986; Sillar and Roberts, 1988; Gerber and Randic, 1989; Pinto and Lev-Tov, 1991) synaptic potentials in the present experiments were insensitive to the NMDA receptor blocker APV. Furthermore, previous studies have shown that substance P, which is released from a subpopulation of DRG neurons, elicits a slow EPSP in spinal cord neurons (Urban and Randic, 1984; DeKoninck and Henry, 199 1; Yoshimura et al, 1992) . The present experiments did not reveal a peptide-mediated EPSP, EPSPs were consistently and completely blocked by CNQX, and a prolonged EPSP was never observed, even after high-frequency presynaptic stimulation. Our finding that baclofen had no postsynaptic effect on spinal cord neurons is consistent with some, but not all previous reports (Lev-Tov et al., 1988; Peng and Frank, 1989 ; but see also Allerton et al., 1989; Kangrga et al., 199 1) . Differences between the present findings and these previous reports may be due to our use of a dissociated cell preparation, or may reflect the use of embryonic tjssue.
Calcium channel subtypes in the control of exocytosis w-CTX consistently and completely abolished evoked excitatory synaptic responses recorded from spinal cord neurons. Several lines of evidence support the hypothesis that this occurred via the toxin's action on presynaptic calcium channels. It has been shown that w-CTX is highly specific for N-type calcium channels in chick sensory neurons (Cox and Dunlap, 1992) . In the present experiments, the calcium-dependent plateau of the DRG action potential was blocked by w-CTX in conjunction with the blockade of synaptic transmission. Furthermore, w-CTX did not alter postsynaptic input resistance, resting membrane potential, or depolarizing responses to L-glutamate. We conclude from these observations that w-CTX-sensitive calcium channels play an essential role in triggering glutamate release from chick DRG axon terminals. This is consistent with the results of Yu et al. (1992) , who found that excitatory transmission between rat sensory neurons and spinal neurons was substantially reduced by w-CTX (Yu et al., 1992) . Cox and Dunlap (1992) demonstrated that w-CTX-sensitive N-type calcium channels carry greater than 85% of the high voltage-activated calcium current recorded from embryonic chick DRG somata. Our present results imply that calcium channel types are the same at the soma and axon terminal of DRG neurons as previously suggested by Lipscombe et al. (1988) . This reinforces the hypothesis that studies of cell bodies are likely to yield insight into mechanisms at less accessible axon terminals.
N channels are known to trigger exocytosis from preparations in both the CNS and PNS of vertebrates (Himing et al., 1988; Miller, 1990) . The diversity of findings in different neural systems, however, underscores the necessity of continued exploration of this area. In rat DRG-spinal neuron cocultures, excitatory transmission between DRG and spinal cord neurons is substantially reduced by w-CTX; by contrast, excitatory transmission between spinal neurons was not altered by w-CTX (Yu et al., 1982) . Pfrieger et al. (1992) have demonstrated that excitatory glutamatergic transmission between rat thalamic neu- rons is partially, but not primarily, mediated by w-CTX-sensitive calcium channels. Recent work with peptide and polyamine toxins from funnel web spider venom have identified a new class of calcium channel, termed P-type, that is a candidate for triggering exocytosis from nerve terminals in the mammalian CNS (Llinas et al., 1989; Mintz et al., 1992) . In addition, L-type calcium channels appear to play a minimal role as triggers of transmitter release from neurons, but dominate the control of hormone secretion from endocrine cells (Bean, 1989; Miller, 1990; Plasman et al., 1990) . Thus, a single calcium channel subtype has not evolved for the exclusive control of exocytosis. Whether variation in the functional properties of the calcium channel subtypes has important implications for the control of secretion remains an open and interesting question.
Mechanisms of presynaptic inhibition
The GABA, receptor agonist baclofen reversibly inhibited synaptic transmission between DRG and spinal neurons. This inhibition was presynaptic as shown by the observations that (1) baclofen did not affect postsynaptic (spinal neuron) resting membrane potential, input resistance, or responses to focally applied glutamate, and (2) baclofen reduced both the EPSP and the calcium-dependent portion of the DRG somatic action potential with a similar time course. These results are consistent with the hypothesis that GABA, receptor-mediated presynaptic inhibition at the primary afferent synapse works via modulation of voltage-dependent calcium channels (Dunlap, 198 1; Dolphin and Scott, 1987; Lev-Tov et al., 1988) . Our results support the finding by Alford and Grillner (199 1) that a PTX-sensitive G-protein mediates the presynaptic GABA, response. In addition, our data suggest that presynaptic inhibition is mediated specifically via a reduction in N-type calcium current at the axon terminal.
Interestingly, 10 WM baclofen largely or completely abolished the synaptic response while only partially reducing the calciumdependent plateau of the DRG somatic action potential. Baclofen may reduce the action potential duration at the nerve terminal in a similar, partial manner. Thus, the complete abolishment of the EPSP may reflect not a complete reduction of action potential duration at the nerve terminal, but rather the very steep calcium dependence of neurosecretion (Dodge and Rahamimoff, 1967) . Alternatively, the difference in action of baclofen on the soma and on the synaptic response may be due to the fact that the soma is undergoing dialysis during recording while the nerve terminal is not; dialysis may result in the loss of an important mediator of the somatic GABA, receptor-me-diated response. In support, effects of w-CTX were equally complete on both the DRG somatic action potential and the synaptic response. w-CTX, acting through channel block, should not be susceptible to dialysis.
Some caution must be employed in the interpretation of these results, because modulation of calcium channel function is only one of the reported actions of baclofen. GABA, receptors on neurons in the spinal cord (Allerton et al., 1989; Wang and Dun, 1990; Kangrga et al., 1991) and brain (Newberry and Nicoll, 1984; Gahwiler and Brown, 1985; Howe et al., 1987; Connors et al., 1988) are coupled to the activation of a potassium conductance. Interestingly, GABAergic inputs onto hippocampal CA1 pyramidal neurons are presynaptically inhibited via this potassium conductance . Furthermore, GABA, receptors have been reported to upmodulate A-type potassium current in hippocampal neurons (Saint et al., 1990) . Previous voltage-clamp studies of DRG somatic currents (Dunlap and Fischbach, 1981; Robertson and Taylor, 1986) have shown that baclofen reduces calcium currents without altering resting or voltage-dependent potassium currents. In agreement, our present results revealed a baclofen-induced reduction in the DRG calcium-dependent action potential plateau, but no effects on input resistance or resting membrane potential. Nonetheless, the possibility remains that baclofen altered potassium conductance ih DRG axon terminals without our detecting it.
An additional note of caution is suggested by experiments demonstrating that presynaptic inhibition of secretion in some preparations results from an action of transmitter at a stage subsequent to calcium entry. For example, ACh release from motor nerve endings is inhibited by adenosine under conditions in which nerve terminal calcium channels are blocked (Silinsky, 1984) . More recently, Scholz and Miller (1992) have shown that adenosine inhibits spontaneous transmitter release by cultured hippocampal neurons in a PTX-sensitive manner, even in the absence of functional calcium channels. This finding has been extended by Scanziani et al. (1992) , who studied presynaptic inhibition of miniature EPSPs recorded from CA3 neurons in hippocampal slice cultures. In these studies, miniature EPSPs did not require presynaptic calcium influx through cadmiumsensitive channels. Nonetheless, baclofen strongly inhibited release via a presynaptic action. Unfortunately, an unambiguous study of baclofen's effects on miniature EPSPs was not feasible in our culture system. Because spinal neurons were excited by other spinal neurons as well as DRG neurons, miniature EPSPs would consist of both spinal-spinal and DRG-spinal synaptic potentials. These two types of synaptic potential can only be distinguished from one another when they are evoked by stimulating a specific presynaptic neuron.
It is clear from all of these studies that presynaptic inhibition is likely to involve many distinct mechanisms. Determining the underlying biological rationale for the existence of these separate inhibitory pathways remains a formidable challenge for future studies. In any case, the evolution of multiple mechanisms for the control of transmitter release serves to underscore the significance of presynaptic regulation in the control of synaptic transmission in the nervous system.
